The mammalian POU-domain factor Bm-3.0 (Bm-3, Bm-3a) is a member of the POU-IV class of transcription factors which resemble the C. &guns factor unc-86 in structure, DNA-binding properties and expression in subsets of sensory neurons. Using specific antisera, we have explored the expression of Bm-3.0 in the early development of the mouse nervous system. Bm-3.0 expression begins at embryonic day 8.5 (E8.5) in a specific set of midbrain tectal neurons whose time and place of appearance are consistent with the earliest CNS neurons previously identified using non-specific markers of neural differentiation. By E9.5, Bm-3.0 immunoreactivity also identifies early CNS neurons in the hindbrain and spinal cord. In the peripheral sensory ganglia, Bm-3.0 expression is first observed at E9.0 in migrating precursors of the trigeminal ganglion, followed by the other sensory cranial and dorsal root ganglia, in a rostra1 to caudal sequence. Double-label immunofluorescence with Bm-3.0 and the markers of cell division PCNA and BrdU demonstrate that Brn-3.0 is restricted to the post-mitotic phase of CNS development. In the sensory cranial and dorsal root ganglia, however, Brn-3.0 is expressed in dividing neural precursors, suggesting that the nature or timing of developmental events controlled by Brn-3.0 are distinct in the CNS and peripheral neurons. Restriction of Bm-3.0 expression to post-mitotic CNS neurons demonstrates that Brn-3.0 is not required for neurogenesis or patterning of the neuroepithelium in the CNS, but suggests a role in specification of mature neuronal phenotypes.
Introduction
Neural development can be broadly divided into sequential phases which include neural induction, patterning of the neural tube, lineage determination and differentiation of adult neuronal phenotypes (Joyner and Guillemot, 1994) . Each developmental phase is partially controlled by the action of DNA-binding transcription factors of several structural classes. The timing of the expression of these developmental regulators with respect to the cessation of cell division provides an important clue to their developmental roles. Patterning of the neural tube takes place among dividing neuroepithelial cells and lineage determination or commitment generally also begins while cells are still dividing. However, the initial expression of * Corresponding author, Tel.: +I 619 5341568; Fax: +l 619 5347653. many markers of neural differentiation, and the assumption of adult neuronal morphology, occur in post-mitotic cells.
Currently, much more is known about mammalian transcription factors controlling pattern formation than about those governing subsequent developmental processes. For example, a clear role in hindbrain segmentation has been established for homeobox-containing genes of the Hox family (Kenyon, 1994; Krumlauf, 1994) . Defects in these patterning genes, produced by targeted mutation of embryonic stem (ES) cells, produce gross anatomical defects in the nervous system and structural abnormalities of the overlying muscle and skeletal structures (Chisaka et al., 1992; Lufkin et al., 1992; Kessel, 1993) . Also using ES cell methods, the murine homeobox gene En-2 has been shown to be essential to the normal morphogenesis of the hindbrain and cerebellar region (Joyner et al., 0925-4773/95/$09.50 0 1995 Elsevier Science Ireland Ltd. All rights reserved SSDI 0925-4773(95)00435-4 1991). Other classes of factors, also related to Drosophila expression is clearly initiated in the dividing precursors of homeotic genes, may serve to pattern more rostra1 brain these neurons, as expected for a lineage determining facstructures .
tor. In contrast to the control of pattern formation in the nervous system, the factors controlling the development of specific mammalian neuronal types remain relatively obscure. Recent studies have shown that the helix-loophelix containing factor Mash-l is necessary for development of specific olfactory and autonomic neural lineages (Johnson et al., 1990; Guillemot et al., 1993) . Mash-l We have been engaged in studies of Brn-3.0 (Brn-3, Brn-3a; He et al., 1989; Gerrero et al., 1993) and Brn-3.2 (Brn-3b; Lillicrop et al., 1992; Xiang et al., 1993; Turner et al., 1994) , members of the 'POU-IV' class of transcription factors, a subset of the larger POU family (Wegner et al., 1993) . The Brn-3 factors show remarkable structural similarity to the POU-domain transcription factor unc-86, which is critical for differentiation of certain neuronal classes in C. elegans (Finney et al., 1988) . In some neuronal lineages, unc-86 expression is activated before the cessation of cell division, and it plays a lineage-determining role (Finney and Ruvkun, 1990) . Unc-86 expression persists in differentiated neurons, where it serves to maintain cell identity. It is reasonable to speculate that the Brn-3 factors may have a similar role in mammalian development. tracts were used for gel-shift assays (see Section 4) with an oligonucleotide probe containing a high affinity Bm-3.O/Bm-3.2 binding site GCATAAATAATAGGG (Turner et al., 1994) . Antiserum prepared against Bm-3.0 supershifted a band corresponding to Bm-3.0 protein (lanes 2,3) but exhibited no cross reactivity with Bm-3.2 (lanes 4,5).
Recent evidence has suggested that Brn-3.0 and Brn-3.2 are expressed in the terminal phase of neuronal differentiation (Gerrero et al., 1993; Turner et al., 1994) , in marked contrast to the Hox genes and other factors mediating neural pattern formation and lineage determination. Particularly in light of the role of unc-86 in determining sensory lineages in C. elegans, we sought to define the precise ontogeny of Brn-3.0, and the timing of its expression with respect to the cessation of cell division. Here we show that the neural transcription factor Brn-3.0 is expressed in dividing precursors of the sensory ganglia in the peripheral nervous system, in a manner which is consistent with a role similar to that of unc-86. In the CNS, the expression of Brn-3.0 identifies a class of very early differentiated neurons in the midbrain, hindbrain, and spinal cord, which coincide in timing and location with the first differentiated CNS neurons identified by prior studies of neuronal birth dates and expression of less specific neural markers. In the CNS, Brn-3.0 expression is restricted to post-mitotic neurons, excluding a role analogous to unc-86 in the commitment of dividing neural precursors. The expression of Brn-3.0 exclusively in the post-mitotic phase of the differentiation of mammalian CNS neurons, combined with the persistence of Brn-3.0 expression in specific nuclei in the postnatal brain, suggests a distinct developmental role for this factor in the terminal differentiation and maintenance of specific adult neuronal phenotypes.
Results

Brn-3.0 expression identifies early CNS neurons
Preliminary studies of Brn-3.0 and Brn-3.2 have suggested that the expression of these genes is activated in the terminal phase of neural development in each area of their expression. Past in situ hybridization studies were limited to the mid-gestational development of structures such as the midbrain tectum and retina, where neuroepithelial and post-mitotic cell layers can be easily distinguished (eg. Fig. 4a,h ). In the present study, development of specific antisera has permitted examination of Brn-3.0 protein at the cellular level, revealing expression of Brn-3.0 much earlier than previously recognized, particularly in the CNS. We have examined early sites of Brn-3.0 expression in the developing midbrain, hindbrain, spinal cord and peripheral sensory ganglia. These early expression patterns of Brn-3.0 have been analyzed by correlation with groups of cells previously shown to be generated early in brain development in birthdating and immunohistochemical studies, and comparison with the persisting expression of Brn-3.0 in specific regions of the postnatal brain, permitting most of the earliest Brn-3.0 neurons to be tentatively identified.
The first detectable developmental expression of Brn-3.0 immunoreactivity was observed in occasional cells near the midline of the rostra1 mesencephalic tectum at embryological day 8.5 (E8.5), prior to closure of the anterior neuropore (not shown). These first Brn-3.0 immunoreactive cells do not express proliferating cell nuclear antigen (PCNA, see below) and thus have probably exited the cell cycle even at this early stage. They cannot be definitively assigned to any adult structure, but may contribute to the mesencephalic nucleus of the trigeminal (MesV, see Section 3). These early tectal neurons have significantly increased in number by the next stage examined, E9.0 (20 somites, not shown). By E9.5 (27 somites), two groups of Brn-3.0 immunoreactive mesencephalic neurons can clearly be identified (Figs. 2a,c, 4f ). The more caudal group consists of cells of the MesV which are numerous near the mesencephalon/metencephalon junction ( Fig. 2c, boxed) . These are characteristically large neurons which resemble primary sensory neurons in the peripheral ganglia. Brn-3.0 antisera also reveal neurons with the characteristic location and morphology of MesV neurons in the postnatal mouse (Fig. 3d) where selective monoclonal antibodies have been previously used to identify these neurons surrounding the lateral borders of the aqueduct in the colliculi and extending caudally into the peduncles of the cerebellum Gilbert, 1990, 1991) .
At E9.5, Brn-3.0 expression also characterizes a growing population of very early midbrain neurons whose size and position are not typical of MesV cells. In contrast to neurons bf the MesV, they are distinctly smaller, more darkly staining and extend rostrally into the pretectum. Location in the pretectum, which is confirmed at E12.5 by the presence of Brn-3.0 immunoreactive cells adjacent to the fibers of the posterior commissure (not shown), suggests that not all of the very early Brn-3.0 immunoreactive cells contribute to MesV (see Section 3). The expression pattern of Brn-3.0 in the tectum postnatally (Fig.  3a ) cannot be used to establish the exact identity of these early tectal/pretectal neurons because Brn-3.0 immunoreactive cells continue to be generated throughout midbrain development.
In the cervical spinal cord, Brn-3.0 immunoreactive neurons are observed along the dorsolateral margin of the spinal neuroepithelium as early as E9.5. By E10.5 (Fig.  2g) , the dorsal cells form a distinct layer and occasional weakly positive cells are observed among the differentiating ventral motoneurons. The ventral staining appears to be transient, because in the postnatal cervical spinal cord (Fig. 3f) , Brn-3.0 immunoreactive neurons appear concentrated primarily in the intermediate gray and spare the ventral horn. In the caudal medulla, Brn-3.0 immunoreactive neurons appear in a pattern similar to that in the spinal cord. Brn-3.0 positive cells appear at the dorsolateral margin of the caudal medulla at about E9.5 and are prominent by E10.5 (not shown). These cells appear far too early in development to contribute to the prominent Brn-3.0 expression in the inferior olive (Fig. 3e) , which develops much later, but may contribute to the numerous Brn-3..0 positive medullary reticular cells. At E10.5, a group of post-mitotic Brn-3.0 neurons appear in the ventral part of the caudal pons/rostral medulla (Figs. 2f, 4g ). The developmental fate of this ventral group is somewhat unclear. The position of these cells suggests that they contribute to cranial motor nuclei, but of the motor nuclei, only the nucleus ambiguus shows significant Brn-3.0 immunoreactivity in the postnatal mouse (Fig. 3e ).
Early Brn-3.0 expression in sensory ganglia
Expression in the peripheral nervous system was first detected in migrating precursors of the trigeminal ganglion at E9.0 (21 somites, not shown). By E9.5, the trigeminal ganglion was morphologically distinct (Fig. 2b ,e) and numerous migrating immunoreactive cells were seen in the vestibulocochlear cranial nerve complex and the dorsal root ganglia (Fig. 2c-e) , followed slightly later by the IX-X cranial nerve complex (not shown). It cannot be determined from this study whether the Brn-3.0 immunoreactive migrating cranial ganglion precursor cells originate from neural crest or from the trigeminal and otic placodes. However, expression of Brn-3.0 in the migrating DRG precursors demonstrates that at least this population of neural crest cells expresses Brn-3.0. Among neuronal groups residing outside the CNS, only the sensory ganglia were Brn-3.0 immunoreactive and signal was not observed in the autonomic ganglia. A very small number of Brn-3.0 immunoreactive cells were consistently noted within the mesenchyme of the first and second branchial arches at E9.5 and E10.5, but signal was not detectable in arch-derived structures at later developmental stages. In contrast, Brn-3.0 expression persisted in all sensory ganglia in the postnatal mouse.
Later CNS development
Brn-3.0 expression in the CNS was examined in detail at several later embryonic stages and in the neonatal mouse. These results were generally consistent with prior layer of Brn-3.0 immunoreactive retinal ganglion cells in situ hybridization studies in the rat (Gerrero et al., was present, and by El55 ( Fig. 2h ), Brn-3.0 was ex-1993; Turner et al., 1994) and, in many cases, the later pressed in a majority of cells in the extensive ganglion sections helped to identify cells seen in the early embryo.
cell layer. The most rostra1 sites of Brn-3.0 expression were in In the midbrain tectum, large numbers of Brn-3.0 imthe medial and lateral habenula or epithalamus and in the munoreactive neurons were generated around E12.5. retina. The first habenular cells were detected at E12.5. In E13.5 ( Fig. 4a , and data not shown), with marked thickenthe retina weak expression of Brn-3.0 was detected in a ing of the post-mitotic cell layer, consistent with the prefew cells as early as E12.5. By E13.5 a centrally located viously observed principal period of neurogenesis in the rat tectum (Altman and Bayer, 1981) . By E13.5, stratification of the Brn-3.0 positive neurons into distinct layers was observed and the organization of layers of immunoreactive cells of differing size and intensity of staining was also observed in the midbrain postpartum (Fig. 3a,b) . Brn-3.0 expressing cells were also noted in the pretectum of the neonatal mouse, including the medial pretectal nucleus, and scattered cells surrounding the habenulo-peduncular tract. In the midbrain tegmentum, Brn-3.0 positive neurons previously detected by in situ hybridization (Turner et al., 1994) were confirmed in the red nucleus, interpeduncular nucleus (Fig. 3b,c ) and large cells of the mesencephalic nucleus of the trigeminal (Fig. 3d ). In addition, immunoreactivity was detected in midbrain nuclei not previously recognized by in situ hybridization, including the nucleus of the lateral lemniscus and midline nuclei of the oculomotor reflex system.
In the hindbrain, Brn-3.0 immunoreactivity confirmed high levels of expression in the postnatal inferior olive and nucleus ambiguus and revealed numerous, scattered Brn-3.0 positive reticular cells in the caudal medulla (Fig.  3e) . In spinal cord sections from neonatal embryos (Fig.  3f) , Brn-3.0 was detected in selected cells primarily in the dorsal and intermediate gray but was not significantly expressed in the motor ventral horn neurons.
Proliferating cell nuclear antigen as a marker for dividing cells in the developing mouse nervous system
The proliferating cell nuclear antigen (PCNA) is an accessory protein of replication which has been used to identify dividing cells in culture and in tissue sections (Waseem and Lane, 1990) and in late mouse embryos . To test the specificity of PCNA in the developing mouse brain under the conditions used for immunohistochemistry of Brn-3.0, we first examined the embryonic mesencephalon at El35 where dividing and post-mitotic cell layers were distinguished by division into a clear ventricular neuroepithelium and a post-mitotic outer zone. Under the conditions of fixation and staining used in this study, PCNA labeled virtually all cells in the neuroepithelium (Fig. 4a,b,d ), suggesting that PCNA was detectable throughout the cell cycle in the proliferating cells. Staining was most intense at the outer margin of the neuroepithelial layer where cells undergo Sphase . Depending on staining condit'ions and photographic exposure time, faint residual staining was sometimes visible in post-mitotic cells adjacent to the neuroepithelial layer ( Fig. 4b ) but this diminished quickly with increasing distance from the neuroepithelium.
Previous reports have variously suggested that PCNA is detectable throughout the cell cycle (Bravo and Macdonald-Bravo, 1985) , in S plus part of G, phase (Takahashi and Caviness, 1993) or in S-phase alone (Leibovici et al., 1992) . It is likely that conditions of fixation significantly affect the detection of PCNA. The antigen is not well preserved in frozen sections, and it may be adequately fixed by organic solvents only during S-phase, due to its interaction with replicating DNA (Hall and Woods, 1990) , while in formalin-fixed specimens such as those in the current study, it is preserved at other phases of the cell cycle as well.
To further examine the specificity of PCNA, we compared PCNA expression in early embryos with the pattern of nuclear incorporation of bromodeoxyuridine (BrdU) in utero. Pregnant mice were injected with BrdU essentially as previously described for labeling dividing cortical neuroblasts at later developmental stages (Miller and Nowakowski, 1988; Takahashi et al., 1992) . The fraction of cells labeled with BrdU was dependent on labeling time relative to cell cycle length, which varied regionally in the embryo. Following the 6 h labeling period used, antibodies to PCNA and BrdU gave similar results when applied to adjacent sections, although BrdU labeled a smaller percentage of cells (Fig. 4d ,e) for proliferating cells in the E9.5 tectum. The BrdU-positive cells appeared to comprise a subset of those immunoreactive for PCNA, consisting of those proliferating cells which passed through S-phase during the BrdU labeling period. Because PCNA labeled cells more inclusively, it provided a more sensitive marker of cell division than pulse-labeling with BrdU, and thus a more stringent test for excluding the presence of dividing cells in a given region. In contrast, because of the gradual disappearance of PCNA from postmitotic cells, BrdU was a more specific marker of cell division, somewhat underestimating the number of dividing cells but providing a more stringent test for confirming their presence.
Distinct developmental timing of Brn-3.0 expression in the CNS and PNS
Because the timing of the expression of a regulatory factor with respect to exit from the cell cycle gave an important clue to its developmental function, we examined each cell group expressing Brn-3.0 on or before E10.5 with Brn-3.0 plus PCNA antisera. In each CNS site, including midbrain tectum (Fig. 4a-e) , the cells of the MesV located at the midbrain-hindbrain junction (Fig.  4f) , the ventral pons, (Fig. 4g) , and in the E9.5 spinal cord (not shown), the initial neurons expressing Brn-3.0 were negative for PCNA, demonstrating that these early cells were postmitotic. In addition, in regions such as the mesencephalon, where postmitotic cells accumulated in a layer away from the ventricle, and mitoses occurred next to the ventricle, the location of the cells confirmed that cell division did not take place in the Brn-3.0 expressing cell population. Finally, a direct examination for mitotic figures was carried out in sections of the E9.5 and E. 10.5 mesencephalic tectum, stained for Brn-3.0 with peroxidase/DAB (see Section 4) and counterstained with methyl green; no mitotic figures was detected in Brn-3.0-positive cells in these CNS sections. In the retina, like other CNS locations, the Brn-3.0 positive cells first detected at El25 were negative for PCNA and were restricted to a clear layer distinct from the neuroepithelium. By El55 the Brn-3.0 immunoreactive ganglion cells formed a thick layer of differentiating neurons within the PCNA-positive neuroepithelium (Fig. 4h) . The pattern of Brn-3.0 expression with respect to cell division in the sensory peripheral nervous system was remarkably distinct from the pattern observed in the CNS. Brn-3.0 immunoreactivity was first detected in migrating neural crest precursors of the trigeminal ganglion at E9.0, and by E10.5, the trigeminal ganglion was anatomically distinct, with extensive Brn-3.0 expression (Fig. 5a) . At E10.5, Brn-3.0 and PCNA co-localized in many of the trigeminal neural precursors (not shown). To exclude the possibility of residual PCNA immunoreactivity in postmitotic cells, trigeminal cells were also examined for BrdU incorporation ( Fig. 5b-d) , which confirmed the presence of a significant fraction of dividing neural precursors. Similarly, a significant fraction of the earliest Brn-3.0 positive cells in the dorsal root ganglia at E9.5 were also positive for PCNA (Fig. 5e) . Finally, the expression of Brn-3.0, in dividing cells in the precursors of the E10.5 trigeminal ganglion (Fig. 5f ) and vestibulocochlear ganglion (Fig. 5g) , was confirmed directly by the detection of mitotic figures in Brn-3.0 immunoreactive cells.
At E9.5 in the tectum, and in the dorsal part of the hindbrain and spinal cord, the Brn-3.0 positive cells generally appeared to be the only cells which did not express PCNA, although it could not be excluded from this examination that other classes of neurons had also stopped dividing at this stage. However, in the ventral medulla and ventral motor area of the spinal cord, some postmitotic neurons were clearly negative for Brn-3.0.
To confirm that the Brn-3.0 neurons are among the first to differentiate, Brn-3.0 expression was compared to that of the cytoskeletal protein 160 kDa neurofilament (NFI60), a widely expressed marker of terminal neuronal differentiation.
In the early El0 (27 somites) embryo, neurofilament immunoreactivity in the CNS was highly restricted to a few discrete areas consistent with the regions of earliest neuronal differentiation previously described using other cytoskeletal markers (Easter et al., 1993) . In the midbrain at this stage, NF160 immunoreactivity clearly co-localized to the region of Brn-3.0-positive cells. In the caudal midbrain, NF160 was observed surrounding Brn-3.0 positive neurons of the MesV nucleus at the isthmus ( Fig. 6a, boxed; Fig. 6b) , and a few fibers just lateral to the Brn-3.0 immunoreactive cells in the ventral pons (Fig. 6a, arrow) . In the dorsal root ganglia of a 27 somite embryo, NF160 immunoreactivity was detectable only in ceils positive for Brn-3.0 (Fig. 6c) , clearly demonstrating that Brn-3.0 identified the first differentiated DRG neurons. By E10.5 (40 somites, Fig. 6d ), numerous axons extended from these neurons to their peripheral targets.
Discussion
Pioneer neurons in the CNS
The detailed examination of the developmental expression of Brn-3.0 has revealed a specific molecular link between several of the earliest sites of CNS neuronal differentiation which have previously been associated only by less specific methods such as birthdating or by the early expression of general neuronal markers. Prior studies in several classes of vertebrates have revealed populations of 'pioneer neurons' whose terminal mitosis and differentiation occur exceptionally early in brain development. In amphibians, Rohon-Beard cells, Mauthner's neurons and several other neuronal classes undergo their final mitosis during late gastrulation (Lamborghini, 1980) . Some of these 'primary neurons', such as the Rohon-Beard sensory neurons, have exclusively larval functions and do not persist in the adult (Forehand and Farel, 1982) . In the chick, hindbrain reticular neurons appear to be the first to differentiate. Some of these cells undergo their final division in the presomite embryo and first express neurofilament at about the 8 somite stage (Sechrist and Bronner-Fraser, 1991) . Early neuronal differentiation in the rodent brain has been studied by birthdating via incorporation of 3H-thymidine and by examining expression of neuronal markers such as neuron-specific cytoskeletal proteins. Developmental studies in the mouse have detected postmitotic neurons as early as the six-somite stage (McConnell, 1981) . Survival studies indicate that about 400 of these neurons arise at or before E8.5 and consist primarily of neurons of the reticular system, the MesV and the superior olive. However, these very early cells represent only a fraction of the cells in each of these nuclei. Studies of rat development indicate that the MesV is the only area in which a majority of cells are born before the developmental stage equivalent to mouse E10.5 (Altman and Bayer, 1980b) . Some species differences in the timing of neuronal development are not surprising, especially in cases where early-appearing neurons serve a species-specific function, such as the early neurons which control swimming in amphibian larvae.
Early mesencephalic neurons
The first appearance of Brn-3.0 immunoreactivity in the developing mouse is in the alar plate of the mesencephalon at E8.5. The timing and position of these initial Brn-3.0 immunoreactive neurons correspond well to the first differentiating neurons seen anywhere in the mouse embryo using antibodies to the non-specific neuronal marker-class III&tubulin (Easter et al., 1993) . By E9.5, a layer of these postmitotic midbrain neurons extends from the pretectum to the isthmus or midbrain/hindbrain junc- tion. The position and morphology of the more caudal midbrain neurons are consistent with the mesencephalic nucleus of the trigeminal (MesV) and neurons of the MesV are also clearly identified by Brn-3.0 antisera in the caudal midbrain of the postnatal mouse in characteristic position at the margin of the mesencephalic central gray (Fig. 3d) . MesV cells have been recognized in several studies as among the first CNS neurons to differentiate in the chick, rat and mouse; they are the only primary sensory neurons in the CNS and studies in chimeric avian embryos have suggested that these cells originate from cranial neural crest rather than the mesencephalic neuroepithelium (Narayanan and Narayanan, 1978) . Experiments using incorporation of 3H-thymidine in the rat (Altman and Bayer, 1980b) have shown that most of the MesV cells are born on or before day El 1, approximately equivalent to mouse day E9 by the dating system used in this study and consistent with the first detection of Brn-3.0 immunoreactivity in postmitotic MesV neurons described here. This nucleus has also been identified using monoclonal antibodies selective for sensory neurons Gilbert 1990, 1991 ) revealing a developmental pattern of expression consistent with that of Brn-3.0 in MesV neurons.
Brn-3.0 immunoreactive neurons in the early developing mesencephalon clearly extend through the rostra1 tectum and pretectal area, but not into the presumptive thalamus (Altman and Bayer, 1995) , obeying a rostra1 limit of expression which appears to lie at the boundary of the synencephalon and paraencephalon (Marin and Puelles, 1994 ) also called prosomeres Pl and P2 . This embryonic division also corresponds well to the postnatal boundaries of Brn-3.0 expression: At birth, Brn-3.0 is expressed in the superior colliculus and pretectal area but not the thalamus and the only area of expression which lies rostra1 to the pretectum is in the medial and lateral habenula of the epithalamus, where Brn-3.0 expression begins much later in development (Turner et al., 1994) . It is not possible from our results to unambiguously determine the developmental fate of these early tectal neurons and particularly to ascertain whether all of the Brn-3.0 immunoreactive neurons which develop in the mesencephalon by E9.5 eventually contribute to MesV. Brn-3.0 immunoreactive neurons con-tinue to be generated throughout the period of neurogenesis in the tectum which may obscure the early cells.
The most anterior Brn-3.0 cells clearly lie anterior to the most rostra1 extent of MesV in the postnatal brain, suggesting that these may represent a distinct cell group. Furthermore, the early Brn-3.0 positive cells, which are near the midbrain-hindbrain junction and which clearly correspond to MesV cells based on prior studies Gilbert, 1990, 1991; Easter et al., 1993) , are typically larger and more scattered in their distribution than the more rostra1 immunoreactive tectal neurons (Figs. 2a,c,  4f ). Prior birthdating studies in the mouse (McConnell, 1981) have also demonstrated a few midbrain reticular neurons born as early as E9.5. However, the first major previously recognized post-mitotic cell group in the lamina of the rat superior colliculus, the neurons of the intermediate magnocellular zone, do not cease division until E12, approximately equivalent to mouse ElO, and the vast majority of rat tectal neurons follow on El3 or later (Altman and Bayer, 1981) . The early Brn-3.0 cells in the rostra1 tectum/pretectum may have gone undetected in prior birthdating studies because they are few or scattered in the adult, because they selectively undergo programmed cell death and are not present in the adult nervous system similarly to the Cajal-Retzius cells in the forebrain or because they comprise a subset of MesV cells which migrate to a more posterior position later in development. Birthdating studies are now underway to try to determine the developmental fate of these early neurons.
Early neurons in the hindbrain and spinal cord
Brn-3.0 immunoreactivity also allows identification of very early post-mitotic neurons which initially occupy a dorsoiateral position in the caudal medulla and cervical spinal cord, beginning at E9.5. Prior studies in the hindbrain of the chick (Sechrist and Bronner-Fraser, 1991) , rat (Nornes and Morita, 1979; Altman and Bayer, 1980a) and mouse (McConnell, 1981) , have demonstrated a population of hindbrain reticular neurons which differentiates very early. Large numbers of Brn-3.0-positive reticular cells are present postnatally in the caudal medulla and it is likely that these represent the cells identified by Brn-3.0 antisera in the dorsolateral medulla of the early embryo. Other caudal hindbrain nuclei which express Brn-3.0 postnatally, such as the inferior olive and nucleus ambiguus, h&e a defined time and place of origin not consistent with these early Brn-3.0 immunoreactive neurons (Altman and Bayer, 1980a) .
Based on prior birthdating studies (Altman and Bayer, 1984) , the location and timing of the first Brn-3.0 positive neurons in the cervical cord indicate that these are neurons of the intermediate spinal gray, perhaps contralaterally projecting sensory relay neurons. This is consistent with the pattern of expression of Brn-3.0 in the postnatal (Pi) spinal cord. These results demonstrate the appearance of post-mitotic spinal relay neurons about one developmental day earlier than the equivalent day reported in survival studies in the rat (Altman and Bayer, I984) , but is more consistent with previous studies in the mouse (Nornes and Carry, 1978; McConnell, 1981) , and suggest that, in the cervical mouse cord, the first neurons in the intermediate and ventral zones arise about the same time (E9.5).
In summary, development of the earliest Brn-3.0 immunoreactive neurons in the midbrain, dorsal medulla and spinal cord coincides with the development of the earliest of the major cell groups in these areas which have been previously identified by birthdating studies and by general markers of differentiated neurons in the rat and mouse. In addition, the very early differentiation of Brn-3.0 expressing neurons, relative to other neurons in these CNS loci, is supported in the present study by markers of cell division, which show that these cells are surrounded by dividing neuroblasts, and by the association of Brn-3.0 immunoreactivity with the earliest sites of CNS neurofilament expression. With the exception of the primary sensory neurons of the MesV, it is plausible to suggest that most or all of the Brn-3.0-positive CNS 'pioneer' neurons comprise a specific class of neurons which may share some functional role, possibly as reticular or relay neurons in the midbrain, hindbrain and spinal cord.
Developmental expression of Brn-3.0 in peripheral sensory ganglia
Brn-3.0 expression in the cranial sensory ganglia and dorsal root ganglia clearly exhibits a different timetable with respect to the cessation of cell division from that in the CNS. Co-localization of Brn-3.0 with PCNA and BrdU both confirm Brn-3.0 expression in numerous dividing precursors of cranial and dorsal root ganglion neurons. Continuing cell division in the trigeminal ganglion after the condensation of migrating trigeminal precursors is well established (Altman and Bayer, 1982) with the generation of the majority of trigeminal neurons on rat E12-14, equivalent to E9.5-11.5 in this study. The appearance of Brn-3.0 in dividing sensory neural precursors suggests either that this factor has distinct roles in differentiating CNS and PNS neurons or that the developmental timing of the transcriptional events presumably controlled by Brn-3.0 is different in these two sets of neurons.
In the cranial sensory ganglia, the data in the present study do not allow us to clearly determine whether the migrating Brn-3.0 immunoreactive neural precursors are of neural crest, placodal origin or a mixture of both. However, expression of Brn-3.0 in migrating dorsal root ganglion precursors suggests at least some of these cells originate in neural crest. Because postnatal expression of Brn-3.0 in the periphery is restricted to cells within the sensory ganglia, and is not detected in other crest derivatives, Brn-3.0 appears to be an early specific marker for migrating truncal neural crest cells fated to contribute to the dorsal root ganglia. The expression of Brn-3.0 in di-viding sensory precursors suggests that it is an especially Several members of the Hox family (Chisaka et al., important marker of early neural crest differentiation, 1992; Lufkin et al., 1992; Kessel, 1993) and En-2, a because previous studies in the chick have demonstrated mammalian homologue of the Drosophila homeotic gene that the expression of general neural markers, such as engrailed (Joyner et al., 1992) , have been shown to have tetanus toxin receptor, appears in sensory ganglia only a role in patterning the mammalian hindbrain. The exfollowing cessation of cell division (Rohrer and Thoenen, pression pattern of several mammalian structural homo-1986). However, we cannot rule out the possibility that logues of other Drosophila developmental regulators also Brn-3.0 is expressed initially in crest cells with other suggests a role in segmental or regional patterning, infates, and subsequently downregulated, or that there is cluding genes of the PAX family (Goulding et al., 1993 ; selective survival of Brn-3.0 positive crest cells which are Stoykova and Gruss, 1994) and recently discovered incorporated into the ganglia. Although the overwhelming homologues of Drosophila developmental genes exmajority of Brn-3.0 immunoreactive cells were located pressed in the forebrain . within the nervous system, occasional positive cells were Some of these patterning genes show persisting expresnoted within the first and second branchial arch at E9.5, sion in the mature brain but are initially expressed in diwhich were not evident at later stages in arch-derived viding neuroepithelial cells and many are not restricted to structures.
neural tissues. The remarkable structural similarity between the Brn-3 gene family and the C. &guns neurodevelopmental gene unc-86 has suggested that like Unc-86, the Brn-3 gene product might play a role in sensory neural lineage determination (He et al., 1989) . Unc 86 is expressed in a heterogeneous group of neuronal precursors, where it appears in 1 of 2 daughter cells following cell division in several neuronal lineages, often 2 or 3 rounds of cell division prior to the terminal mitosis (Finney and Ruvkun, 1990) . Because Brn-3.0 expression in peripheral ganglia is activated prior to the cessation of cell division such a role remains a possibility in the PNS. However, in all CNS sites examined, Brn-3.0 is only expressed following exit from the cell cycle and thus it cannot be required for lineage determination in dividing CNS neuroblasts. In the CNS it also appears that Brn-3.0 does not distinguish one of two post-mitotic daughter cells with different fates, because in many CNS sites (demonstrated particularly clearly in the retina, Fig. 4h ), virtually all of the initial post-mitotic cells to differentiate are positive for Brn-3.0.
Transcription factors in patterning and terminal di&erentiation
Neural development can be broadly divided into induction of the neuroepithelium, regionalization or patterning, proliferation and lineage determination and terminal differentiation with expression of cell-specific gene products (Joyner and Guillemot, 1994) . The timing of the expression of developmental regulators with respect to cell division plays a critical role with respect to the stage of the development in which they act and all steps except terminal differentiation occur in dividing neural precursors. The expression of genes controlling pattern formation in the neuroepithelium will obey or define segmental or structural boundaries, but may be expressed in diverse cell types within a region. In contrast, genes controlling terminal differentiation should be expressed in cells which share common phenotypic features which may or may not follow segmental restrictions.
Much less is known about transcriptional control of later developmental events in the mammalian nervous system. The POU-domain transcription factor SCIP (Tst-1, Ott-6) is expressed in dividing glial cell precursors and acts as a repressor of terminal glial differentiation (Monuki et al., 1990 (Monuki et al., , 1993 , perhaps serving to delay expression of myelin until the appropriate developmental time. SCIP also has expression in specific post-mitotic cortical neurons (Frantz, et al 1994) where its role is less clear. Another proven developmental regulator in mammals is the helix-loop-helix factor Mash-l. Unlike genes with a patterning role, Mash-l is required for development of an anatomically diffuse group of neurons of the olfactory epithelium and sympathetic ganglia (Guillemot et al., 1993) . Mash-l is expressed in dividing precursor cells in these neuronal lineages and appears to act at an early step in the genesis of these neurons. In marked contrast to these established examples, the expression patterns of Brn-3.0 described here, and less conclusive data regarding Brn-3.2 (Turner et al., 1994) , suggest that these genes belong to a distinct functional class of developmental regulators whose role, at least in the CNS, is restricted to the post-mitotic phase of development. Among previously described neural transcription factors, the expression of Brn-3.0 with respect to exit from the cell cycle may most closely resemble that of the LIM-homeodomain protein Isl-1 in terminally differentiating motor neurons (Ericson et al., 1992) .
In summary, the earliest Brn-3.0 expressing CNS neurons coincide with the first cells to differentiate in the alar plate of the midbrain, medulla and spinal cord. Comparison with prior studies, using general neuronal markers, indicates that the early midbrain expression of Brn-3.0 may provide a specific marker for the first differentiated neurons to appear in any region of the mouse brain. In the CNS, Brn-3.0 is restricted to highly specific sets of postmitotic neurons and is not expressed in dividing neuroepithelial cells. For this reason, Brn-3.0 is unlikely to establish segmental boundaries, although in some cases it appears to follow them, but it appears likely to play a role in controlling the differentiated phenotype of specific neurons.
Brn-3.0 must not be required for neurogenesis in the CNS, because it appears only after the cessation of cell division. In contrast, in the PNS, the expression of Brn-3.0 in dividing neural precursors allows the possibility of a role analogous to unc-86 in lineage determination. These results also predict that if null mutations at the Brn-3.0 locus reveal a reduced population of CNS neurons in brain regions which express this factor, similar to the loss of anterior pituitary cells in naturally occurring null mutants of the pituitary developmental factor Pit-l (Li et al., 19901 , such an effect will necessarily be mediated by reduced cell survival rather than by a reduction in the number of Brn-3.0 neurons generated.
Experimental procedures
I. Animals
Timed pregnancies for all embryological studies employed IO-week BALB-c female mice which were mated with C57BL/6 males at night and examined for the appearance of a mucous plug the following morning. Noon of the day of plug discovery was designated as embryological day 0.5 (E0.5). This convention is consistent with that widely used in mouse embryology (Theiler, 1989; Kaufman, 1992) , but differs from that previously used for many neuronal birthdating studies in rat embryos, in which the day of the mucous plug is designated embryological day 1 (Altman and Bayer, 1995) . The day of birth is designated postnatal day zero (PO) and neonatal mice were analyzed on day Pl. Where required for identification of dividing cells by bromodeoxyuridine (BrdU) immunohistochemistry, two injections of BrdU in saline, at a dosage of 5Opg/g total body weight (Takahashi et al., 1992) were administered by intraperitoneal injection at 3 h intervals beginning at noon of the appropriate developmental day. Embryos were harvested 3 h after the second injection and processed for immunohistochemistry as described below.
Preparation of Brn-3.0-specific antisera
The marked similarity of the protein sequence of the three mammalian members of the POU-IV class, Brn-3.0, Brn-3.1 and Brn-3.2, present a problem for the development of specific immunochemical reagents. Although the POU-IV proteins represent products of different genes (Gerrero et al., 1993; Turner et al., 1994) , they possess virtually identical carboxy-terminal DNA-binding POU domains and extended regions of similarity of unknown function near their amino-termini.
Production of a monospecific Brn-3.0 polyclonal antibody was achieved by immunization with an 80 amino acid region of Brn-3.0 protein which represents its only extended region of divergence with Brn-3.1 and Brn-3.2. The corresponding 240 base-pair fragment of Brn-3.0 cDNA, which resides immediately 5' to the POU-specific domain (Turner et al., 1994) , was inserted in-frame into the glutathione-S-transferase fusion vector pGEX (Smith and Johnson, 1988) and the &galactosidase fusion vector PAX-5 (USB). Bacterial protein was expressed and affinity purified from both constructs according to established protocols. Purified GST-Brn-3.0 fusion protein was injected uncleaved into rabbits with Freund's incomplete adjuvant, followed by 3-5 subsequent immunizations at 6 week intervals with Freund's incomplete adjuvant. Serum from immunized rabbits was treated with PMSF, diluted 1: 1 with PBS and applied to an affinity column consisting of the B-galactosidase-Brn-3.0 fusion protein immobilized on Affigel 15 (Bio-rad) according to manufacturer's instructions. Bound immunoglobulin was eluted with 0.1 M glycine (pH 2.5), neutralized with Tris base and dialyzed against PBS/glycerol for use in all immunohistochemical procedures.
The specificity of resulting Brn-3.0 antisera was tested by Western blotting of cell and tissue samples extracted directly into SDS-page sample buffer and by antibodyperturbated gel-shift assays, as previously described (Turner et al., 1994) . Western immunoblotting of protein extracts from adult mouse trigeminal ganglia (not shown) revealed a major band of M, 43 000, consistent with the predicted size of the Brn-3.0 cDNA open reading frame, and a second fainter band representing a slightly smaller Brn-3.0 variant protein. The appearance of this doublet in in vitro translation product from cloned Brn-3.0 cDNA suggests that the smaller band results from utilization of an alternate initiator methionine rather than alternative splicing of the Brn-3.0 message.
When tested in gelshift assays, the resultant antiserum formed a complex with Brn-3.0 protein derived from CV-1 cells transfected with a Brn-3.0 expression plasmid, but not with similarly expressed Brn-3.2, the closest molecular relative to Brn-3.0 (Fig. 1) . For preparation of Brn-3.0 protein, CV-1 cells were transfected by the calcium phosphate co-precipitation method (Ausubel et al., 1994 ) and whole cell extracts were prepared by the method of Scholer et al., (1989) . Finally, the specificity of the Brn-3.0 antiserum was supported by the similarity of immunohistochemical results (below) to previous in situ hybridization studies in the developing rat embryo (Gerrero et al., 1993; Turner et al., 1994; E. Turner, unpublished data) .
Immunohistochemistty
Timed pregnant animals were sacrificed and embryos washed in PBS, followed by fixation in 6 parts ethanol, 1 part 40% formaldehyde and 3 parts dH20 for 30-120 min. Postnatal mice were fixed by perfusion with 4% formaldehyde (final concentration) in PBS, followed by immersion in the fixative above. Specimens were washed in 70% ethanol, dehydrated in isopropanol, embedded in histoplast and sectioned at 4 pm on a rotary microtome.
Single-label immunohistochemistry for Brn-3.0 was performed by incubation with an appropriate dilution of affinity-purified rabbit anti-Brn-3.0 in PBS/S% goat serum, followed by either goat anti-rabbit FITC conjugate (Vector) for immunofluorescence or by donkey antirabbit IgG horseradish peroxidase conjugate (Amersham), followed by staining with metal-enhanced DAB and H202 according to manufacturer's protocol (Pierce). Doublelabel immunofluorescence to assess the mitotic state of Brn-3.0 immunoreactive cells was performed by simultaneous incubation with affinity purified anti-Brn-3.0 and mouse monoclonal anti-PCNA (Novocastra) or anti-BrdU (Sigma), followed by FITC goat anti-rabbit IgG and Texas Red goat anti-mouse IgG conjugates (Molecular Probes). Neurofilament expression in differentiating neurons was detected with anti-160 kDa neurofilament (Sigma), followed by Texas Red goat anti-mouse secondary antibody. Immunofluorescence studies were conducted with an Olympus BH2 microscope equipped for epifluorescence with a 75W Xenon light source.
